Tao, L., et al., 2017. Improved HIV-1 viral load monitoring capacity using pooled testing with marker-assisted deconvolution. Journal of acquired immune deficiency syndromes (1999), 75, p.580.

Miriam O, L.-O., et al., 2017. Task shifting and skin punch for the histologic diagnosis of Kaposi’s sarcoma in sub-Saharan Africa: A public health solution to a public health problem.

Coffie, P.A., et al., 2017. Trends in hepatitis B virus testing practices and management in HIV clinics across sub-Saharan Africa. BMC infectious diseases, 17, p.141–148.

Tierney, W.M., et al., 2016. Assessing the impact of a primary care electronic medical record system in three Kenyan rural health centers. Journal of the American Medical Informatics Association, 23, p.544–552.

Saito, S., et al., 2016. Declining tuberculosis incidence among people receiving hiv care and treatment services in east Africa, 2007–2012. Journal of acquired immune deficiency syndromes (1999), 71, p.e96.

Nakanjako, D., et al., 2016. Frequency and impact of suboptimal immune recovery on first-line antiretroviral therapy within the International Epidemiologic Databases to Evaluate AIDS in East Africa. AIDS (London, England), 30, p.1913.

Huang, A., et al., 2016. Global comparison of drug resistance mutations after first-line antiretroviral therapy across human immunodeficiency virus-1 subtypes. In Open forum infectious diseases. Oxford University Press, p. ofv158.

Gregson, J., et al., 2016. Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study. The Lancet infectious diseases, 16, p.565–575.

Brooks, K., et al., 2016. HemaSpot, a novel blood storage device for HIV-1 drug resistance testing. Journal of clinical microbiology, 54, p.223–225.

Saito, S., et al., 2016. Implementation and operational research: Declining tuberculosis incidence among people receiving HIV care and treatment services in East Africa, 2007–2012. JAIDS Journal of Acquired Immune Deficiency Syndromes, 71, p.e96–e106.

Dicko, F., et al., 2016. Implementation of tuberculosis intensive case finding, isoniazid preventive therapy, and infection control (" Three I's") and HIV-tuberculosis service integration in lower income countries.

Bonnet, M., et al., 2016. Mycobacterium tuberculosis lineage 4 comprises globally distributed and geographically restricted sublineages.

Stucki, D., et al., 2016. Mycobacterium tuberculosis lineage 4 comprises globally distributed and geographically restricted sublineages. Nature genetics, 48, p.1535–1543.

Camlin, C.S., et al., 2016. Patient-reported factors associated with reengagement among HIV-infected patients disengaged from care in East Africa. AIDS (London, England), 30, p.495.

Diero, L. & Kambugu, A., 2016. Patient-reported factors associated with reengagement among HIV-infected patients disengaged from care in East Africa.

Geng, E.H., et al., 2016. Retention in care and patient-reported reasons for undocumented transfer or stopping care among HIV-infected patients on antiretroviral therapy in Eastern Africa: application of a sampling-based approach. Clinical Infectious Diseases, 62, p.935–944.

Diero, L., Kemboi, E. & Orido, M., 2016. Treatment failure and drug resistance in HIV-positive patients on tenofovir-based first-line antiretroviral therapy in western Kenya.

Brooks, K., et al., 2016. Treatment failure and drug resistance in HIV-positive patients on tenofovir-based first-line antiretroviral therapy in western Kenya. Journal of the International AIDS Society, 19, p.20798.

Huis, D., et al., 2015. Determinants of weight evolution among HIV-positive patients initiating antiretroviral treatment in low resource settings. Journal of acquired immune deficiency syndromes (1999), 70, p.146.

Green, E.P., et al., 2015. Do clinical decision-support reminders for medical providers improve isoniazid preventative therapy prescription rates among HIV-positive adults?: study protocol for a randomized controlled trial. Trials, 16, p.1–8.

Green, E.P., et al., 2015. Do clinical decision-support reminders for medical providers improve isoniazid prescription rates among HIV-positive adults?.

Geng, E.H., et al., 2015. Estimation of mortality among HIV-infected people on antiretroviral treatment in East Africa: a sampling based approach in an observational, multisite, cohort study. The lancet HIV, 2, p.e107–e116.

Rachlis, B., et al., 2015. Evaluating outcomes of patients lost to follow-up in a large comprehensive care treatment program in western Kenya. Journal of acquired immune deficiency syndromes (1999), 68, p.e46.

Huang, A., et al., 2015. Global comparison of drug resistance mutations following first line antiretroviral therapy across HIV-1 subtypes. In Open Forum Infect Dis.

Rachlis, B., et al., 2015. Implementation and operational research: evaluating outcomes of patients lost to follow-up in a large comprehensive care treatment program in western Kenya. JAIDS Journal of Acquired Immune Deficiency Syndromes, 68, p.e46–e55.